Profile: AtriCure Inc (ATRC.O)
21 Feb 2017
AtriCure, Inc., incorporated on October 31, 2000, is a medical device company providing atrial fibrillation (Afib) solutions. The Company's segment develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. The Company has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. The Company offers various minimally invasive ablation devices and access tools to facilitate less invasive cardiac and thoracic surgery. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA). The Company's products are utilized by cardiothoracic surgeons during both open-heart and minimally invasive procedures, either on a concomitant or sole-therapy basis. The Company's Isolator Synergy System, which includes its Isolator Synergy clamps, radio frequency (RF) generator and related switchbox, provides treatment for persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair. The Company has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion.
Product lines for cardiac tissue ablation
Physicians use the Isolator Synergy System and related RF devices in both open and minimally invasive procedures. The Company's Isolator Synergy and Isolator Synergy Access Clamps are sold in multiple configurations of its Isolator Synergy clamps. Its configuration is optimized for ablation during open-heart procedures and others for minimally invasive procedures. The Company's Isolator Synergy Ablation and Sensing Unit (ASU) is a compact generator that delivers bipolar radio frequency energy to its Isolator Synergy clamps, pens and the Coolrail linear ablation device. The Company's AtriCure Switch Box (ASB) is a compact switch box, which provides the technology needed for the dual pulsing electrodes in its Isolator Synergy clamps, as well as the ability to connect and toggle between its multiple RF devices. Its Isolator multifunctional pens are disposable RF devices that come in two configurations: one that makes linear ablations and one that makes spot ablations. The pens enable surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device. Its Coolrail linear ablation device is a disposable linear RF ablation device designed to allow physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. Its COBRA Fusion Surgical Ablation System's Versapolar technology combines bipolar temperature-controlled radio frequency (TCRF) energy control with monopolar energy. The COBRA Fusion System also incorporates a suction design that draws tissue into the device to create consistent, full thickness lesions without arresting and opening the heart.
The Company's Electrosurgical Unit (ESU) is a compact power generator for use with COBRA Fusion ablation products. Its AFfirm Bipolar Pacing Probe is used to test lesions created in surgically treating the patient's arrhythmia. Its EPi-Sense Guided Coagulation System with VisiTrax technology is intended for the coagulation of cardiac tissue using RF energy using thoracoscopic, endoscopic and laparoscopic surgical techniques. The Company's minimally invasive SUBTLE approach utilizes the Cannula as an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach, which allows surgeons direct visualization while ablating on the posterior of the heart. The Company's nContact RF generator is a compact power generator for use with EPi-Sense Guided Coagulation System with VisiTrax technology. The Company's cryoICE cryoablation system consists of the cryoICE BOX generator along with a range of cryoICE single use and reusable cryosurgery probes. The cryoICE cryoablation system is used to ablate cardiac tissue for the treatment of cardiac arrhythmias and to provide temporary pain relief to thoracic surgery patients via ablation of peripheral nerves.
Product line for left atrial appendage management
The Company's AtriClip system is designed to exclude the left atrial appendage by mechanically clamping the appendage from the outside, eliminating blood flow between the left atrial appendage and the atrium while avoiding contact with circulating blood. The AtriClip portfolio includes a range of devices with different size clips, as well as different applier lengths and deployment features. The different configurations allow various uses covering both open and minimally invasive surgery.
The Company competes with Medtronic, Inc.
7555 Innovation Way
MASON OH 45040-9695
Company Web Links
- BRIEF-Atricure announces preliminary results
- BRIEF-Hudson Executive Capital reports 5.6 pct stake in AtriCure
- BRIEF-AtriCure announces preliminary results for Q4 and FY 2016
- BRIEF-Atricure names Sven Wehrwein to its board of directors
- BRIEF-Atricure announces approval for Cryoice(TM) platform in Japan